TCL Archive Treatment Progress Increases Five Year Survival To 41%; Rates Compared For 10 Leading Cancers April 25, 1980
TCL Archive Scientists Tell Panel: Peer Review Need Improving, Available Funds Should Be Spread Over More Grants April 30, 1982
TCL Archive ODAC Votes to Nix Amgen’s Drug Xgeva For Proposed Prostate Cancer Indication February 17, 2012